September 05, 2010

CLOSE
confirmation text

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

Advances in Psoriasis and Inflammatory Skin Diseases

» Advanced search

Latest Issue

Volume 1 Issue 2

Leading ArticlesClick to expand
- Psoriatic Arthritis as a Risk Factor for the Development of Cardiovascular Disease
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)
  
  Michael T Nurmohamed, MD, PhD
  
  Departments of Internal Medicine and Rheumatology, VU University Medical Centre;  Department of Rheumatology, Jan van Breemen Institute, Amsterdam, The Netherlands
  
  The increased rate of mortality that is seen in patients with psoriatic arthritis (PsA) is predominantly due to atherosclerotic cardiovascular (CV) disease. CV morbidity is also increased in patients with PsA compared with the general population.
  This increased CV risk might be related to an increased prevalence of CV risk factors or undertreatment of CV risk factors in patients with PsA.
  
  » Read more
- Psychological Distress in Patients with Psoriasis Vulgaris
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)
  
  Francesca Sampogna, BD, MPH 
  
  Health Services Research Unit, Istituto Dermopatico dell’Immacolata (IDI)-IRCCS, Rome, Italy
  
  The presence of psoriasis is often associated with psychological distress and/or psychiatric co-morbidities. In particular, depression, anxiety, and difficulties in expressing emotions have been observed at a much higher prevalence in patients with psoriasis than in the general population.
  
  » Read more
- The Role of Keratinocytes in Inflammatory Skin Diseases
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)
  
  Cristina Albanesi, PhD 
  
  Laboratory of Immunology, Istituto Dermopatico dell’Immacolata (IDI)-IRCCS, Rome, Italy 
  
  Substantial evidence that has been acquired over recent years indicates that keratinocytes play an active role in the generation and expression of protective immune responses in the skin. The constitutive production of immune and inflammatory mediators by unperturbed keratinocytes is low or absent. However, upon stimulation by environmental, physical, or chemical stimuli, a significant increase in the production of pro-inflammatory mediators can be observed both in vitro and in vivo.
  
  » Read more
Clinical ReviewsClick to expand
- Biological Therapies
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
- Biomarkers
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
- Psoriatic Arthritis
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
- Lichen Planus
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
- Treatment of Autoimmune Disease
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
- Miscellaneous
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)
  
  » Read more
Meeting ReportsClick to expand
- An Update from the International Congress of Dermatology 2009
  
  in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Meeting Reports)
  
  » Read more

« Back

READER POLL

Which therapy would you first use to treat a patient with newly diagnosed, severe plaque psoriasis?

Topical agents
Methotrexate
Anti-TNF agents
Cyclosporine
Phototherapy
Other

Your First Name

Your Surname

Recipient's Email Address *

To automatically send an email containing a link to this page, please enter the recipient's email address and your name (optional).

Find us on
Facebook

Post Page On

SUBMIT AN ARTICLE

» Click here

© Remedica 2010. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

Produced and published by Remedica Medical Education and Publishing Limited.

September 05, 2010 CLOSE confirmation text Produced and published by Remedica Medical Education and Publishing Limited. » Contact us

Latest Issue

Volume 1 Issue 2

Leading Articles »

Michael T Nurmohamed, MD, PhD

Francesca Sampogna, BD, MPH

Cristina Albanesi, PhD

Clinical Reviews »

Meeting Reports »

Volume 1 Issue 2

Leading ArticlesClick to expand

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)

Michael T Nurmohamed, MD, PhD

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)

Francesca Sampogna, BD, MPH

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Leading Articles)

Cristina Albanesi, PhD

Clinical ReviewsClick to expand

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Clinical Reviews)

Meeting ReportsClick to expand

in Advances in Psoriasis and Inflammatory Skin Diseases (Volume 1 Issue 2 / Meeting Reports)

READER POLL

Post Page On

SUBMIT AN ARTICLE

September 05, 2010

CLOSE
confirmation text

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

Francesca Sampogna, BD, MPH 

Cristina Albanesi, PhD 

Francesca Sampogna, BD, MPH 

Cristina Albanesi, PhD 